Our observations indicate that patients with lower ratios of epoxides to diols at baseline (ischemia) tend to have larger infarct sizes, which highlights the potential involvement of the soluble epoxide hydrolysis (sEH) enzyme in STEMI patients. This evidence concerns the gene EPHX2 and ST Elevation Myocardial Infarction.